Skip to main content
. Author manuscript; available in PMC: 2023 Apr 26.
Published in final edited form as: Nat Rev Neurol. 2022 Jan 5;18(2):117–124. doi: 10.1038/s41582-021-00595-5

Table 1 |.

Neurogenetic conditions with developmental and degenerative phases

genetic alteration Condition Neurodevelopmental phenotype Developmental brain pathology Degenerative phenotype Degenerative brain pathology
Trisomy 21 Down syndrome Autism, intellectual disability Small cerebrum, small cerebellum, dendritic spine abnormalities Alzheimer disease Alzheimer disease neuropathological changes
FMR1 full mutation (>200 repeats) Fragile X syndrome Autism, intellectual disability, attention deficit hyperactivity disorder Heterotopias, enlarged caudate nucleus, dendritic spine abnormalities Parkinsonism, ataxia Largely unknown
FMR1 pre-mutation (55–200 repeats) Fragile X-associated tremor/ataxia syndrome Autism, anxiety, attention deficit hyperactivity disorder in a subset Ataxia, intention tremor, parkinsonism White matter degeneration, Purkinje cell loss, eosinophilic inclusions within neurons and glia
22q11.2 deletion Velocardiofacial syndrome Learning disabilities, intellectual disability, schizophrenia Variable: polymicrogyria, heterotopias, developmental microvasculopathy Early-onset parkinsonism Nigral degeneration with Lewy body formation
c.598G>A mutation in PPP2R5D NA Intellectual disability Macrocephaly Early-onset parkinsonism Nigral degeneration in the absence of Lewy body pathology
NR4A2 variants NA Intellectual disability Early-onset parkinsonism Yet to be studied post-mortem
RAB39B variants NA Intellectual disability Early-onset parkinsonism Nigral degeneration with Lewy body formation
H3F3A and H3F3B variants NA Intellectual disability Yet to be studied post-mortem Global neurodegeneration Yet to be studied post-mortem
KIF1A variants KIF1A-associated neurological disorder Intellectual disability, seizures, spastic paraplegia Microcephaly Optic nerve atrophy, cerebral and cerebellar atrophy Cerebellar atrophy, dentate nucleus and inferior olivary neuronal loss
HTT expansions Huntington disease Reduced brain growth compared with control individuals, epilepsy in ~25% individuals with juvenile-onset Huntington disease (age of onset <20 years) Brain malformations in a subset, usually single unilateral heterotopias Psychiatric disease, cognitive decline, chorea Striatal degeneration, diffuse brain atrophy, formation of huntingtin aggregates

NA, not applicable.